News of Halter’s $220 million Series E earlier this year—a round that valued the New Zealand livestock technology compan…

K-wellness brand Clöud Café is deepening its Target partnership with a limited-edition holiday collection launching online and in-store endcaps.

Even after a retina loses its natural light-sensing cells, some of its nerve circuitry can remain intact. In a new preclinical study, researchers showed that injectable, light-sensitive nanoparticles can lodge near surviving retinal nerve cells and help degenerated mouse retinas respond to illumination.

Why it matters: The trial will test whether an immune response seen in a small Phase 1 study translates into a clinical benefit for patients.

Lucas Meyer Cosmetics by Clariant has launched KanuFresh, a natural-origin active positioned between conventional deodorants and sweat-control solutions.

As we age, some of the cells in our body enter a state of senescence, in which they stop dividing but do not die. Those senescent cells can contribute to age-related disorders such as cancer, tissue degeneration, and inflammatory diseases.

Why it matters: The project pushes Scarlet’s technology beyond using engineered red blood cells as passive carriers of therapeutic proteins. The aim is to equip them with biological circuits capable of sensing a signal, making a decision and switching a response on or off.

Why it matters: The missing number makes it difficult to assess Roche’s claim that the drug has “best-in-class potential” in an IgAN field where several competitors have already produced placebo-adjusted proteinuria reductions of around 40%-50%.